Search - tctmd.com

Displaying 1 - 20 of 160

Sort: Relevancy | Date

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr.

October 31, 2016

Presentation TCT 2016

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Presenter: Thomas F. Luscher, Patrick W. Serruys, D. Christopher Metzger

October 31, 2016

Presentation TCT 2016

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

Presenter: Kenneth Rosenfield, Sahil A. Parikh

October 31, 2016

Presentation TCT 2016

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Presenter: Sriram S. Iyer, Craig M. Walker, Daniel Ortiz

October 31, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

Caitlin E. Cox

November 15, 2015

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

Presentation TCT 2015

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

Presenter: Cindy L. Grines, John R. Laird Jr

October 14, 2015

Presentation TCT 2015

IN_PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions – Two-Year Outcomes

Presenter: John R. Laird Jr.

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

Advertisement

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

IN_PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions – Two-Year Outcomes

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content